In the last decade,there have been huge advances in the field of breast imaging.Full field digital mammography systems optimise lesion to background contrast with resultant improvement in the sensitivity of the technique for cancer detection, facilitated by computer-aided detection.Though mammography remains the only established modality for population-based screening, preliminary results from several large studies indicate that magnetic resonance imaging(MRI) has a role in high-risk patients.On the other hand, advances in ultrasound, MRI and nuclear medicine have the potential to greatly improve the specificity of breast imaging with regard to cancer detection and lesion characterisation.A number of new and experimental techniques are being developed which may have great impact in this area and these will be discussed. Though MRI now has an established place in the diagnosis of breast cancer, it is becoming clear that it can directly affect surgical and medical management by enabling assessment of response to chemotherapy and endocrine therapy, and facilitating choice of the most appropriate surgery.Just as the role of MRI has evolved,so too the place of nuclear medicine, particularly positron emission tomography and radio-immunoscintigraphy should become clearer in the next few years.

Author

K Planche and S Vinnicombe

Contact Details

Corresponding address:
Radiology Department,
4th floor Outpatients Block,
St Bartholomew’s Hospital,
London EC1,
UK

Reference

ICIS Cancer Imaging volume 4
DOI: 10.1102/1470-7330.2003.0033

Date Posted

12 January 2004

Screen PDF

Size

560.73 KB

Minimum Estimated Download Times

ADSL 2Mb/s (Broadband):	2 seconds
ADSL 512Kb/s (Broadband):	8 seconds
64 Kb/s (ISDN):	1 minute 10 seconds
33.3 Kb/s (Typical Modem):	2 minutes 14 seconds

Print PDF

Size

10.00 MB

Minimum Estimated Download Times

ADSL 2Mb/s (Broadband):	39 seconds
ADSL 512Kb/s (Broadband):	2 minutes 39 seconds
64 Kb/s (ISDN):	21 minutes 19 seconds
33.3 Kb/s (Typical Modem):	40 minutes 59 seconds

No part of this publication or site may be reproduced, stored in a retrieval system, or transmitted in any form or by any means, electronic, mechanical, photocopying, recording or otherwise, without the prior written permission of the Publisher, e-MED Limited, Permissions, PO Box 61053, London, SE16 7YZ. Tel: +44 (0)207 719 8989 Fax: +44 (0)560 126 4446, permissions@cancerimaging.org.